[1]
Nesrin ŞEN and Mehmet Engin TEZCAN 2021. Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19. Archives of Rheumatology. 36, 1 (Mar. 2021), 142–143. DOI:https://doi.org/10.46497/ArchRheumatol.2021.8228.